The origin of ovarian cancer species and precancerous landscape

IM Shih, Y Wang, TL Wang - The American journal of pathology, 2021 - Elsevier
Unlike other human cancers, in which all primary tumors arise de novo, ovarian epithelial
cancers are primarily imported from either endometrial or fallopian tube epithelium. The …

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—shifting the paradigm

RJ Kurman, IM Shih - Human pathology, 2011 - Elsevier
Recent morphologic, immunohistochemical, and molecular genetic studies have led to the
development of a new paradigm for the pathogenesis and origin of epithelial ovarian cancer …

Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review

JM Liberto, SY Chen, IM Shih, TH Wang, TL Wang… - Cancers, 2022 - mdpi.com
Simple Summary Ovarian high-grade serous carcinoma (HGSC) has a 5-year survival rate
of less than 50%, making it one of the most lethal gynecological cancers for women in the …

Hippo signaling in the ovary: emerging roles in development, fertility, and disease

KL Clark, JW George, E Przygrodzka… - Endocrine …, 2022 - academic.oup.com
Emerging studies indicate that the Hippo pathway, a highly conserved pathway that
regulates organ size control, plays an important role in governing ovarian physiology …

Epigenetics in ovarian cancer

Y Natanzon, EL Goode, JM Cunningham - Seminars in cancer biology, 2018 - Elsevier
Ovarian cancer is a disease with a poor prognosis and little progress has been made to
improve treatment. It is now recognized that there are several histotypes of ovarian cancer …

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low‐grade serous carcinoma

YT Tsang, MT Deavers, CC Sun… - The Journal of …, 2013 - Wiley Online Library
BRAF and KRAS mutations in ovarian serous borderline tumours (OSBTs) and ovarian low‐
grade serous carcinomas (LGSCs) have been previously described. However, whether …

DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers

CY Yen, HW Huang, CW Shu, MF Hou, SSF Yuan… - Cancer letters, 2016 - Elsevier
Epigenetic modifications play important roles in regulating carcinogenesis, and specific
epigenetic modifications have emerged as potential tumor markers. Herein, we summarize …

Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles

PK Mankoo, R Shen, N Schultz, DA Levine, C Sander - PloS one, 2011 - journals.plos.org
Background Serous ovarian cancer (SeOvCa) is an aggressive disease with differential and
often inadequate therapeutic outcome after standard treatment. The Cancer Genome Atlas …

Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel

MS Cicek, DC Koestler, BL Fridley… - Human molecular …, 2013 - academic.oup.com
Ovarian cancer remains the leading cause of death in women with gynecologic
malignancies, despite surgical advances and the development of more effective …

LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer

H Wang, Z Fu, C Dai, J Cao, X Liu, J Xu, M Lv, Y Gu… - Scientific reports, 2016 - nature.com
Long noncoding RNA (lncRNA) has been recognized as a regulator of gene expression,
and the dysregulation of lncRNAs is involved in the progression of many types of cancer …